Company Tagline
Unlocking the Opportunity of NAMPT Inhibition
Industry Category
Business Keywords
Company Description
Remedy Plan Therapeutics is a dynamic biotechnology company dedicated to transforming the landscape of NAMPT inhibition. With a pioneering approach that enables highly tunable, hyperbolic inhibition of NAMPT, Remedy Plan Therapeutics is unlocking new possibilities in treating diseases caused by NAMPT dysregulation.
Based in Gaithersburg, MD, Remedy Plan Therapeutics is advancing a robust pipeline of tunable NAMPT inhibitors. Their innovative mechanism of action provides NAMPT inhibition without the severe on-target toxicity typically associated with such treatments, opening opportunities to address solid tumors, hematologic malignancies, obesity, and autoimmune disorders. Remedy Plan Therapeutics' lead asset, RPT1G, boasts a favorable efficacy and tolerability profile and is slated to advance to the clinic in 2024. The company's primary address is in Gaithersburg, MD, US.
Remedy Plan Therapeutics is committed to developing groundbreaking therapies that improve patient outcomes and quality of life. To the manager of Remedy Plan Therapeutics, we invite you to create a customized and exclusive company showcase and product listing on our platform to further enhance your commercial development.
Remedy Plan Therapeutics est une entreprise de biotechnologie dynamique dédiée à la transformation du paysage de l'inhibition de la NAMPT. Grâce à une approche novatrice qui permet une inhibition hyperbolique hautement modulable de la NAMPT, Remedy Plan Therapeutics ouvre de nouvelles possibilités dans le traitement des maladies causées par la dérégulation de la NAMPT.
Basée à Gaithersburg, MD, Remedy Plan Therapeutics fait progresser un pipeline robuste d'inhibiteurs de NAMPT modulables. Son mécanisme d'action innovant permet l'inhibition de la NAMPT sans la toxicité sévère sur cible généralement associée à de tels traitements, ouvrant ainsi des possibilités de traiter les tumeurs solides, les hémopathies malignes, l'obésité et les maladies auto-immunes. L'actif principal de Remedy Plan Therapeutics, RPT1G, affiche un profil d'efficacité et de tolérabilité favorable et devrait être avancé en clinique en 2024. L'adresse principale de l'entreprise est située à Gaithersburg, MD, aux États-Unis.
Remedy Plan Therapeutics s'engage à développer des thérapies révolutionnaires qui améliorent les résultats pour les patients et leur qualité de vie. Au responsable de Remedy Plan Therapeutics, nous vous invitons à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme afin d'améliorer encore votre développement commercial.
Key Personnel / Employees
Compare Companies Side by Side
Compare Remedy Plan Therapeutics with 1 companies in Biotechnology
| Comparison Field |
Remedy Plan TherapeuticsMain Company |
Lantern Pharma Inc....View Profile |
|---|---|---|
|
Founded Year
|
— | 2013 |
|
Company Size
|
— | 11-50 |
|
City
|
Gaithersburg, MD | Dallas, TX |
|
Country
|
United States | United States |
|
Skills & Keywords
Comparing with main company
|
11 Total Skills
Biotechnology
NAMPT Inhibition
Oncology
Autoimmune Disorders
Drug Development
Therapeutics
RPT1G
Cancer Drug Development
NAMPT inhibition
Cancer Stem Cells
Cancer Containment Therapy
|
9 Total
9 Unique
Unique Skills:
Artificial Intelligence
Biomarkers
Companion Diagnostics
Drug Repurposing
Drug Rescue
Genetic Screen
+3
|
2
Total Companies2013
Oldest Founded1
Countries20
Unique SkillsSimilar Companies
Other organizations in the same industry
Atila Biosystems
BiotechnologyWe are committed to bringing innovative nucleic acid amplification and detection technologies to rea...
澳斯康生物Thousand Oaks Biologics Inc.
BiotechnologyMore accessible, affordable biologics for humanity!
Alternative Company Names
This company is also known as